Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.

Related Posts

First-quarter GDP growth will be just 0.3% as tariffs s...

Buzzword News Mar 31, 2025  0  3

EU preparing further countermeasures against U.S. tarif...

Buzzword News Apr 2, 2025  0  2

Here’s how much a 'Made in the USA' iPhone would cost

Buzzword News Apr 14, 2025  0  2

Comments

Name

Email

Comment

Post Comment